These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1666269)

  • 1. Calcium-regulated protein kinases and low Km cGMP phosphodiesterases: targets for novel antihypertensive therapy.
    Silver PJ; Pagani ED; Cumiskey WR; Dundore RL; Harris AL; Lee KC; Ezrin AM; Buchholz RA
    Adv Exp Med Biol; 1991; 308():95-105. PubMed ID: 1666269
    [No Abstract]   [Full Text] [Related]  

  • 2. Intracellular cyclic GMP receptor proteins.
    Lincoln TM; Cornwell TL
    FASEB J; 1993 Feb; 7(2):328-38. PubMed ID: 7680013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of calmodulin and smooth muscle myosin light chain kinase.
    Means AR; VanBerkum MF; George SE; Bagchi IC
    Adv Exp Med Biol; 1989; 255():135-45. PubMed ID: 2559594
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of low Km cGMP phosphodiesterases and Ca+(+)-regulated protein kinases and relationship to vasorelaxation by cicletanine.
    Silver PJ; O'Connor B; Cumiskey WR; Van Aller G; Hamel LT; Bentley RG; Pagani ED
    J Pharmacol Exp Ther; 1991 Apr; 257(1):382-91. PubMed ID: 1850474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ca/CaM-stimulated and cGMP-specific phosphodiesterases in vascular and non-vascular tissues.
    Ahn HS; Foster M; Cable M; Pitts BJ; Sybertz EJ
    Adv Exp Med Biol; 1991; 308():191-7. PubMed ID: 1666264
    [No Abstract]   [Full Text] [Related]  

  • 6. ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells.
    Wyatt TA; Naftilan AJ; Francis SH; Corbin JD
    Am J Physiol; 1998 Feb; 274(2):H448-55. PubMed ID: 9486247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic AMP dependent and myosin light chain kinase: relationship to altered vascular reactivity in hypertension and development of direct pharmacological modulators.
    Silver PJ
    Prog Clin Biol Res; 1987; 245():233-49. PubMed ID: 3685014
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation of contractile activity in vascular smooth muscle by protein kinases.
    Silver PJ
    Rev Clin Basic Pharm; 1985; 5(3-4):341-95. PubMed ID: 3029813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconsideration of the multiple cyclic nucleotide phosphodiesterases in bovine heart.
    Donnelly TE
    Biochem Biophys Res Commun; 1978 Jun; 82(3):964-70. PubMed ID: 212032
    [No Abstract]   [Full Text] [Related]  

  • 10. A new cGMP phosphodiesterase isolated from bovine platelets is substrate for cAMP- and cGMP-dependent protein kinases: evidence for a key role in the process of platelet activation.
    Robichon A
    J Cell Biochem; 1991 Oct; 47(2):147-57. PubMed ID: 1661738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into cGMP action.
    Corbin JD; Thomas MK; Wolfe L; Shabb JB; Woodford TA; Francis SH
    Adv Second Messenger Phosphoprotein Res; 1990; 24():411-8. PubMed ID: 2169819
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of myosin regulatory light chain phosphorylation via cyclic GMP during chemotaxis of Dictyostelium.
    Liu G; Newell PC
    J Cell Sci; 1994 Jul; 107 ( Pt 7)():1737-43. PubMed ID: 7983143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phosphodiesterases of cyclic GMP].
    Wróblewska H; Gorczyca WA
    Postepy Hig Med Dosw; 2001; 55(5):611-27. PubMed ID: 11795198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic-GMP-regulated enzymes and their possible physiological functions.
    Walter U
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():249-58. PubMed ID: 6145321
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclic GMP phosphodiesterases and regulation of smooth muscle function.
    Rybalkin SD; Yan C; Bornfeldt KE; Beavo JA
    Circ Res; 2003 Aug; 93(4):280-91. PubMed ID: 12933699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desensitization of NO/cGMP signaling in smooth muscle: blood vessels versus airways.
    Mullershausen F; Lange A; Mergia E; Friebe A; Koesling D
    Mol Pharmacol; 2006 Jun; 69(6):1969-74. PubMed ID: 16510560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of parotid gland function by cyclic nucleotides and calcium.
    Butcher FR; Putney JW
    Adv Cyclic Nucleotide Res; 1980; 13():215-49. PubMed ID: 6158259
    [No Abstract]   [Full Text] [Related]  

  • 18. Increases of guanosine 3',5'-monophosphate-related enzymes in kidneys of developing rats.
    Schlondorff D; Trizna W
    Pediatr Res; 1978 Aug; 12(8):882-5. PubMed ID: 28509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calponin-calmodulin interaction: properties and effects on smooth and skeletal muscle actin binding and actomyosin ATPases.
    Winder SJ; Walsh MP; Vasulka C; Johnson JD
    Biochemistry; 1993 Dec; 32(48):13327-33. PubMed ID: 8241189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase and cGMP-degrading phosphodiesterase, alterations in hyperammonemia.
    Monfort P; Felipo V
    BMC Pharmacol; 2005 Jun; 5 Suppl 1(Suppl 1):P66. PubMed ID: 15969770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.